Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011

International Journal of Cardiology

Volumn 154, Issue SUPPL. 1, 2011, Pages

  Grünig, Ekkehard ^a   Barner, Andreas ^b   Bell, Michael ^c   Claussen, Martin ^d   Dandel, Michael ^e   Dumitrescu, Daniel ^f   Gorenflo, Matthias ^g   Holt, Stephan ^h   Kovacs, Gabor ⁱ   Ley, Sebastian ^a   Meyer, Joachim F ^j   Pabst, Stefan ^k   Riemekasten, Gabriela ^l   Saur, Joachim ^m   Schwaiblmair, Martin ⁿ   Seck, Cathérine ^f   Sinn, Lutz ^o   Sorichter, Stephan ^p   Winkler, Jörg ^q   Leuchte, Hanno H ^r  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Emergency Unit   (Germany)

^c ALFRIED KRUPP KRANKENHAUS   (Germany)

^d KRANKENHAUS GROSSHANSDORF   (Germany)

^e DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h RUHR UNIVERSITY BOCHUM   (Germany)

ⁱ UNIVERSITY HOSPITAL GRAZ   (Austria)

^j Clinic for Pneumology and Gastroenterology   (Germany)

^k UNIVERSITY HOSPITAL BONN   (Germany)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m UNIVERSITY OF HEIDELBERG   (Germany)

ⁿ UNIVERSITY HOSPITAL AUGSBURG   (Germany)

^o Cardiology Practice   (Germany)

^p UNIVERSITY OF FREIBURG   (Germany)

^q Specialty Practice for Pneumology Fachpraxis Leipzig ^*  (Germany)

^r Clinic Neuwittelsbach   (Germany)

more..

Author keywords

Diagnosis; Echocardiography; Exercise testing; Guidelines; Pulmonary hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; TROPONIN I; TROPONIN T; URIC ACID;

ALGORITHM; ARTERIAL GAS; BLOOD ANALYSIS; CARDIOLOGY; CARDIOPULMONARY EXERCISE TEST; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD HEALTH CARE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; CONSENSUS DEVELOPMENT; CONTRAST ENHANCEMENT; DIAGNOSTIC ALGORITHM; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAM; EUROPE; EXERCISE TEST; FOLLOW UP; GERMANY; HEALTH CARE PLANNING; HEART ATRIUM ENLARGEMENT; HEART DEPOLARIZATION; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; IMMUNOLOGICAL PROCEDURES; LABORATORY TEST; LIVER CIRRHOSIS; LUNG ANGIOGRAPHY; LUNG FUNCTION TEST; LUNG VENTILATION PERFUSION RATIO; NON INVASIVE PROCEDURE; PATIENT CODING; PEDIATRIC CARDIOLOGY; PORTAL HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONOLOGY; STRESS ECHOCARDIOGRAPHY; SYMPTOMATOLOGY; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; TREATMENT INDICATION; WALKING;

BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; EXERCISE TEST; HUMANS; HYPERTENSION, PULMONARY; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY FUNCTION TESTS;

EID: 84855384299     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/S0167-5273(11)70488-0     Document Type: Conference Paper

References (71)

1. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
2. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009;34:1219-63.
3. Hoeper MM, Ghofrani HA, Gorenflo M, Grünig E, Schranz D, Rosenkranz S. Diagnosis and Treatment of Pulmonary Hypertension: European Guidelines 2009. Pneumologie 2010;64:401-14.
4. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23. (Pubitemid 17137857)
5. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet 1998;352:719-25. (Pubitemid 28398718)
6. Tongers J, Schwerdtfeger B, Klein G, et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007;153:127-32. (Pubitemid 44889238)
7. Hoeper MM, Pletz MW, Golpon H, Welte T. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2007;29:944-50. (Pubitemid 46711899)
8. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S55-66.
9. Fisher MR, Criner GJ, Fishman AP, et al. Estimating pulmonary artery pressures by echocardiography in patients with emphysema. Eur Respir J 2007;30:914-21. (Pubitemid 351194795)
10. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005;52:3792-3800. (Pubitemid 41798217)
11. Mukerjee D, St George D, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 2004;43:461-6. (Pubitemid 38489363)
12. Launay D, Mouthon L, Hachulla E, et al. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease. J Rheumatol 2007;34:1005-11. (Pubitemid 46774846)
13. Sitbon O, Lascoux-Combe C, Delfraissy JF, et al. Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med 2008;177:108-13.
14. Grunig E, Weissmann S, Ehlken N, et al. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia. Circulation 2009;119:1747-57.
15. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.J Am Soc Echocardiogr 2010;23:685-713.
16. Bonderman D, Wexberg P, Martischnig A, Heinzl H, Lang M, Sadushi-Kolici R, Skoro-Sajer N, Lang I. A non-invasive algorithm to exclude precapillary pulmonary hypertension. Eur Respir J 2011;37:1096-103.
17. Tunariu N, Gibbs SJ, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007;48:680-4. (Pubitemid 47604965)
18. Resten A, Maitre S, Humbert M, et al. Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. Am J Roentgenol 2004;183:65-70. (Pubitemid 38789013)
19. Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637-48. (Pubitemid 38456010)
20. Reichelt A, Hoeper MM, Galanski M, et al. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol 2009;71:49-54.
21. Fedullo PF, Auger WR, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-72.
22. Marcus JT, Gan CT, Zwanenburg JJ, et al. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol 2008;51:750-7. (Pubitemid 351221219)
23. Torbicki A Cardiac magnetic resonance in pulmonary arterial hypertension, a step in the right direction. Eur Heart J 2007;28:1187-9. (Pubitemid 47343839)
24. Reiter G, Reiter U, Kovacs G, et al. Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging 2008;1:23-30.
25. Rich S, Kieras K, Groves B, et al. Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol. 1986;8:1307-11. (Pubitemid 17208906)
26. Chu JW, Kao PN, Faul JL, et al. High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest. 2002;122:1668-73. (Pubitemid 35366080)
27. Leuchte HH, Baumgartner RA, Nounou ME, Vogeser M, Neurohr C, Trautnitz M, Behr J. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006;173:744-50.
28. Leuchte HH, El Nounou M, Tuerpe JC, Hartmann B, Baumgartner RA, Vogeser M, Muehling O, Behr J. N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension. Chest 2007;131:402-9. (Pubitemid 46280399)
29. Albrecht T, Blomley MJ, Cosgrove DO, et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 1999;353:1579-83. (Pubitemid 29219208)
30. Naeije R. Hepatopulmonary syndrome and portopulmonary hypertension. Swiss Med Wkly 2003;133:163-9. (Pubitemid 36628590)
31. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9.
32. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: guidelines for the six minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
33. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000;161:487-92. (Pubitemid 30129457)
34. Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40:780-8.
35. Paciocco G, Martinez F, Bossone E, et al. Oxygen desaturation on the sixminute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001;17:647-52. (Pubitemid 32492552)
36. Oudiz RJ, Barst RJ, Hansen JE, et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 2006;97:123-6. (Pubitemid 41828135)
37. Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002;106:319-24. (Pubitemid 34778955)
38. Ross RM. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:1451. (Pubitemid 36609732)
39. Palange P, Ward SA, Carlsen KH, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007;29:185-209. (Pubitemid 46092015)
40. Yasunobu Y, Oudiz RJ, Sun XG, Hansen JE, Wasserman K. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005;127:1637-46. (Pubitemid 46218789)
41. Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom DM. Exercise-induced pulmonary arterial hypertension. Circulation 2008;118:2183-9.
42. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001;104:429-35. (Pubitemid 32678273)
43. Groepenhoff H, Vonk-Noordegraaf A, Boonstra A, Spreeuwenberg MD, Postmus PE, Bogaard HJ. Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc 2008;40:1725-32.
44. Bonow RO, Carabello BA, Kanu C, de Leon AC, Jr., Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jr., Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231.
45. Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Hesse C, Troster N, Salmhofer W, Stauber R, Fuerst F, Thonhofer R, Ofner-Kopeinig P, Gruenig E, Olschewski H. Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: Echocardiography versus right heart catheterisation. Chest 2010;138:270-8.
46. Himelman RB, Stulbarg M, Kircher B, Lee E, Kee L, Dean NC, Golden J, Wolfe CL, Schiller NB. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease. Circulation 1989;79:863-71. (Pubitemid 19100546)
47. Argiento P, Chesler N, Mule M, D'Alto M, Bossone E, Unger P, Naeije R. Exercise stress echocardiography for the study of the pulmonary circulation. Eur Respir J 2010;35:1273-8.
48. Grunig E, Janssen B, Mereles D, Barth U, Borst MM, Vogt IR, Fischer C, Olschewski H, Kuecherer HF, Kubler W. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 2000;102:1145-50.
49. Alkotob ML, Soltani P, Sheatt MA, Katsetos MC, Rothfield N, Hager WD, Foley RJ, Silverman DI. Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma. Chest 2006;130:176-81. (Pubitemid 44116857)
50. Collins N, Bastian B, Quiqueree L, Jones C, Morgan R, Reeves G. Abnormal pulmonary vascular responses in patients registered with a systemic autoimmunity database: Pulmonary Hypertension Assessment and Screening Evaluation using stress echocardiography (PHASE-I). Eur J Echocardiogr 2006;7:439-46. (Pubitemid 44645060)
51. Pignone A, Mori F, Pieri F, Oddo A, Galeota G, Fiori G, Del Rosso A, Perfetto F, Becucci A, Livi R, Tempestini A, Benvenuti C, Gramigna L, Fedi R, Generini S, Minelli M, Cinelli M, Guiducci S, Arcangeli C, Conforti ML, Bernardo P, Cerinic MM. Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci 2007;1108:291-304. (Pubitemid 47528742)
52. Callejas-Rubio JL, Moreno-Escobar E, de la Fuente PM, Perez LL, Fernandez RR, Sanchez-Cano D, Mora JP, Ortego-Centeno N. Prevalence of exercise pulmonary arterial hypertension in scleroderma. J Rheumatol 2008;35:1812-6.
53. Steen V, Chou M, Shanmugam V, Mathias M, Kuru T, Morrissey R. Exerciseinduced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 2008;134:146-51. (Pubitemid 352008776)
54. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, Das C, Elliot CA, Johnson M, DeSoyza J, Torpy C, Goldsmith K, Hodgkins D, Hughes RJ, Pepke-Zaba J, Coghlan JG. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009;179:151-7.
55. Kovacs G, Maier R, Aberer E, et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med 2009;180:881-6.
56. Ha J-W, Choi D, Park S, et al. Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction. Heart 2009;95:490-4.
57. Shim CY, Kim S-A, Choi D, et al. Clinical outcomes of exercise-induced pulmonary hypertension in subjects with preserved left ventricular ejection fraction: implication of an increase in left ventricular filling pressure during exercise. Heart 2011 [Epub ahead of print].
58. Voelkel MA, Wynne KM, Badesch DB, et al. Hyperuricemia in severe pulmonary hypertension. Chest 2000;117:19-24. (Pubitemid 30053614)
59. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000;102:865-70.
60. Williams MH, Handler CE, Akram R, et al. Role of N-terminal brain natriuretic peptide (NTproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 2006;27:1485-94. (Pubitemid 43998084)
61. Fijalkowska A, Kurzyna M, Torbicki A, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006;129:1313-21.
62. Andreassen AK, Wergeland R, Simonsen S, et al. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Am J Cardiol 2006;98:525-9. (Pubitemid 44162883)
63. Torbicki A, Kurzyna M, Kuca P, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003;108:844-8. (Pubitemid 37022127)
64. McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation 2006;114:1417-31. (Pubitemid 44454562)
65. Eysmann SB, Palevsky HI, Reichek N, et al. Two-dimensional and Dopplerechocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation 1989;80:353-60. (Pubitemid 19195745)
66. Raymond RJ, Hinderliter AL, Willis PW, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002;39:1214-9. (Pubitemid 34267428)
67. Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006;174:1034-41. (Pubitemid 44684453)
68. Tei C, Dujardin KS, Hodge DO, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 1996;9:838-47.
69. Yeo TC, Dujardin KS, Tei C, et al. Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol 1998;81:1157-61. (Pubitemid 28232689)
70. Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, Koch A, Falkenberg J, Mir TS. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009;30:3-8.
71. Koestenberger M, Ravekes W, Everett AD, Stueger HP, Heinzl B, Gamillscheg A, Cvirn G, Boysen A, Fandl A, Nagel B. Right ventricular function in infants, children and adolescents: Reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values. J Am Soc Echocardiogr 2009;22:715-9.